New Pediatric Labeling Information Database - Detail

Please note: JavaScript must be enabled for this application to work properly.
Check your settings if you are unsure
if your JavaScript is enabled.

Pediatric Labeling Date:

09/20/2007

Trade Name:

Norditropin Cartridges

Generic Name or Proper Name (*):

somatropin (rDNA origin)

Indications Studied:

Treatment of short stature in children with Turner syndrome

Label Changes Summary:

* Safety and effectiveness based on studies in pediatric patients * New Warning: Patients with Turner syndrome should be evaluated carefully for otitis media and other ear disorders since these patients have an increased risk of ear and hearing disorders. Somatropin treatment may increase the occurrence of otitis media in patients with Turner syndrome. In addition, patients with Turner syndrome should be monitored closely for cardiovascular disorders (e.g., stroke, aortic aneurysm/dissection, hypertension) as these patients are also at risk for these conditions * Information on recommended dosing, adverse events (AEs) and clinical studies * New indication